Extended Data Table 3 GMT of neutralizing antibodies against SARS-CoV-2 stratified by the pre-existing anti-Ad5 neutralizing antibody titers

From: Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

  1. Data are GMT (95% CI), n= the number of participants included the intervention modified intention-to-treat cohort. The p values are the results of comparison between pre-existing anti-Ad5 neutralizing antibody titer ≤ 1:200 and pre-existing anti-Ad5 neutralizing antibody titer > 1:200. GMT = geometric mean titer.
Back to article page